ARIXA PHARMACEUTICALS
Arixa Pharmaceuticals is developing oral antibiotics for resistant Gram-negative infections, an urgent need. Their lead program is an oral prodrug of Avibactam, a broad spectrum beta-lactamase inhibitor recently approved by FDA. They have addressed and solved the medicinal chemistry issues which complicate the prodrugging of this class of compounds, and expect to receive broad composition of matter patent protection.
ARIXA PHARMACEUTICALS
Industry:
Emergency Medicine Health Care Pharmaceutical
Founded:
2016-01-01
Address:
Palo Alto, California, United States
Country:
United States
Website Url:
http://www.arixapharma.com
Total Employee:
11+
Status:
Closed
Email Addresses:
[email protected]
Total Funding:
13 M USD
Technology used in webpage:
SPF Dyn DNS Dyn Hosting
Current Employees Featured
Founder
Official Site Inspections
http://www.arixapharma.com
- Host name: 192.29.61.237
- IP address: 192.29.61.237
- Location: Zurich Switzerland
- Latitude: 47.4049
- Longitude: 8.4631
- Timezone: Europe/Zurich
- Postal: 8102
Loading ... 